Gal Hacohen Kleiman

Gal Hacohen Kleiman

Auto-generated profile, based on publicly available information

Gal Hacohen Kleiman

Elton Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience and Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Biological Psychiatry
Verified
Journal Article
Closed access
GKGidon Karmon
Gidon Karmon
SSShlomo Sragovich
Shlomo Sragovich
GHGal Hacohen-Kleiman
Gal Hacohen-Kleiman
IBInbar Ben-Horin-Hazak
Inbar Ben-Horin-Hazak
PKPetr Kasparek
Petr Kasparek
Illana GozesIllana Gozes
Illana Gozes

24 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMohiuddin Mohiuddin
Mohiuddin Mohiuddin
ZMZlatko Marusic
Zlatko Marusic
MAMirna Anicic
Mirna Anicic
VAVan Dijck Anke
Van Dijck Anke
ECElisa Cappuyns
Elisa Cappuyns
CPChristopher E. Pearson
Christopher E. Pearson
Many neurodevelopmental disorders, including autism, are caused by de novo mutations, that might arise as early as in the parental germline, during embryonic, fetal development, or as late as post-natal aging. Intra-tissue mutation-load variations could impact clinical presentation. One of the most common causes of autism is de novo mutations in ADNP . We developed an ultra-sensitive, highly-quantitative droplet digital PCR assay to determine ADNP mutation levels in patient tissues, including blood, teeth, hair, and 24 different tissues from a post-mortem de novo ADNP -mutated child (∼6-years old), including a transplanted liver from a non-mutant donor (retained for 22 months). Striking variations of ADNP mosaicism arose between tissues of the same individual. Mutation load differences were evident between post-mortem tissues, but not in the transplanted liver — supporting a cell autonomous genetic vulnerability to de novo mutations, arguing against a transferable environmentally-sensitive DNA damage/mutation predisposition. Variations between tissues suggest a developmental timing of the mutations. Most individuals showed at least one tissue with less than heterozygous mutations, where the presence of the homozygous non-mutant cells indicates that de novo ADNP mutations arose post-zygotically. Highly variable ADNP mosaicism between tissues, that within an individual can be less than heterozygous or approach homozygosity, indicate rapid ongoing post-zygotic, and possibly post-natal, somatic mutations, contributing to clinical variability.